NoneRandom: Monster Hunter's Got to Have the Best Motion Capture in Gaming
Up 99% in the Past Year, How High Can This Growth Stock Rise?Bello's 20 lead Purdue Fort Wayne past Drexel 87-81
Natixis Advisors LLC boosted its stake in Texas Roadhouse, Inc. ( NASDAQ:TXRH – Free Report ) by 3.5% during the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 31,832 shares of the restaurant operator’s stock after buying an additional 1,066 shares during the period. Natixis Advisors LLC’s holdings in Texas Roadhouse were worth $5,622,000 as of its most recent SEC filing. Other hedge funds also recently added to or reduced their stakes in the company. CIBC Asset Management Inc increased its holdings in shares of Texas Roadhouse by 3.3% in the 3rd quarter. CIBC Asset Management Inc now owns 1,952 shares of the restaurant operator’s stock worth $345,000 after acquiring an additional 62 shares during the period. PSI Advisors LLC increased its stake in shares of Texas Roadhouse by 70.8% in the third quarter. PSI Advisors LLC now owns 181 shares of the restaurant operator’s stock valued at $32,000 after purchasing an additional 75 shares during the period. Angeles Wealth Management LLC raised its holdings in shares of Texas Roadhouse by 5.4% during the third quarter. Angeles Wealth Management LLC now owns 1,469 shares of the restaurant operator’s stock valued at $259,000 after buying an additional 75 shares during the last quarter. Benjamin F. Edwards & Company Inc. boosted its position in shares of Texas Roadhouse by 12.9% during the second quarter. Benjamin F. Edwards & Company Inc. now owns 743 shares of the restaurant operator’s stock worth $128,000 after buying an additional 85 shares during the period. Finally, Gries Financial LLC grew its holdings in Texas Roadhouse by 6.5% in the 2nd quarter. Gries Financial LLC now owns 1,876 shares of the restaurant operator’s stock worth $322,000 after buying an additional 114 shares in the last quarter. 94.82% of the stock is currently owned by institutional investors. Analyst Ratings Changes Several brokerages have weighed in on TXRH. Citigroup lifted their target price on Texas Roadhouse from $192.00 to $201.00 and gave the company a “buy” rating in a research note on Tuesday, October 1st. Stephens upped their price target on shares of Texas Roadhouse from $170.00 to $176.00 and gave the company an “equal weight” rating in a report on Monday, July 29th. Wells Fargo & Company lifted their target price on Texas Roadhouse from $165.00 to $175.00 and gave the stock an “equal weight” rating in a report on Friday, July 26th. Morgan Stanley upped their target price on Texas Roadhouse from $200.00 to $205.00 and gave the company an “equal weight” rating in a report on Friday, October 25th. Finally, Loop Capital dropped their price target on Texas Roadhouse from $215.00 to $209.00 and set a “buy” rating on the stock in a research note on Monday, October 28th. Twelve analysts have rated the stock with a hold rating and eleven have issued a buy rating to the company’s stock. Based on data from MarketBeat, Texas Roadhouse currently has a consensus rating of “Hold” and a consensus target price of $189.00. Texas Roadhouse Trading Up 1.2 % NASDAQ TXRH opened at $194.90 on Friday. Texas Roadhouse, Inc. has a 1 year low of $110.88 and a 1 year high of $203.32. The company has a market cap of $13.00 billion, a P/E ratio of 33.35, a P/E/G ratio of 1.65 and a beta of 0.98. The company has a fifty day simple moving average of $182.88 and a 200 day simple moving average of $173.59. Texas Roadhouse ( NASDAQ:TXRH – Get Free Report ) last issued its earnings results on Thursday, October 24th. The restaurant operator reported $1.26 earnings per share for the quarter, missing the consensus estimate of $1.32 by ($0.06). Texas Roadhouse had a net margin of 7.65% and a return on equity of 31.33%. The business had revenue of $1.27 billion for the quarter, compared to analyst estimates of $1.27 billion. During the same quarter last year, the firm posted $0.95 earnings per share. Texas Roadhouse’s revenue was up 13.5% on a year-over-year basis. Equities research analysts forecast that Texas Roadhouse, Inc. will post 6.39 EPS for the current fiscal year. Texas Roadhouse Dividend Announcement The company also recently declared a quarterly dividend, which will be paid on Tuesday, December 31st. Stockholders of record on Tuesday, December 10th will be paid a dividend of $0.61 per share. This represents a $2.44 annualized dividend and a dividend yield of 1.25%. The ex-dividend date is Tuesday, December 10th. Texas Roadhouse’s dividend payout ratio (DPR) is presently 41.92%. Insider Activity at Texas Roadhouse In other news, Director Donna E. Epps sold 610 shares of the business’s stock in a transaction dated Monday, November 11th. The stock was sold at an average price of $195.66, for a total transaction of $119,352.60. Following the completion of the transaction, the director now directly owns 3,532 shares in the company, valued at approximately $691,071.12. The trade was a 14.73 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink . Also, CTO Hernan E. Mujica sold 1,500 shares of the company’s stock in a transaction that occurred on Thursday, November 14th. The shares were sold at an average price of $202.26, for a total transaction of $303,390.00. Following the completion of the sale, the chief technology officer now directly owns 16,342 shares of the company’s stock, valued at $3,305,332.92. The trade was a 8.41 % decrease in their position. The disclosure for this sale can be found here . 0.50% of the stock is owned by company insiders. Texas Roadhouse Profile ( Free Report ) Texas Roadhouse, Inc, together with its subsidiaries, operates casual dining restaurants in the United States and internationally. It also operates and franchises restaurants under the Texas Roadhouse, Bubba's 33, and Jaggers names in 49 states and ten internationally. Texas Roadhouse, Inc was founded in 1993 and is based in Louisville, Kentucky. Featured Stories Want to see what other hedge funds are holding TXRH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Texas Roadhouse, Inc. ( NASDAQ:TXRH – Free Report ). Receive News & Ratings for Texas Roadhouse Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Texas Roadhouse and related companies with MarketBeat.com's FREE daily email newsletter .Dr. Ekua Amoako, a communications team member of the New Patriotic Party (NPP), has questioned the ongoing attacks by the National Democratic Congress (NDC) on Electoral Commissioner Jean Mensa, calling out the party’s persistent accusations of election rigging. In a statement, Dr. Amoako expressed concern over the NDC’s repeated claims that the Electoral Commission (EC) is attempting to manipulate election results. She pointed out that despite these allegations, the NDC had secured a significant margin of victory in several areas, questioning where the supposed rigging had taken place. “We made efforts to ensure peaceful elections. Yet, every day, the NDC accuses the EC of rigging. They will continue to say this, but they managed to win with a significant margin, so where is the rigging?” Dr. Amoako said. She further expressed sympathy for Jean Mensa, who has been the focal point of these attacks. “The focus on Jean Mensa is so intense that at times, I feel for her. What is her crime? Her only crime is being the EC. She is simply trying to do the right thing,” Dr. Amoako added. Dr. Amoako also defended the re-coalition of seven disputed constituencies, which had been the subject of contention following a High Court ruling. She argued that the re-coalition process was necessary, claiming that some polling agents had been pressured to declare results in favor of the NDC. The seven constituencies—Ahafo Ano North, Techiman South, Ahafo Ano South West, Nsawam Adoagyiri, Obuasi East, Okaikwei Central, and Tema Central—were all declared for the NPP after the re-collation. Following this process, the NDC’s General Secretary, Fifi Fiavi Kwetey, condemned the re-collation, describing it as unlawful and manipulated, and announced that the NDC rejected the results. Dr. Amoako’s comments reflect a deepening divide between the NPP and NDC over the credibility of the Electoral Commission’s actions, especially concerning the re-collation of results and the allegations surrounding it.Even with access to blockbuster obesity drugs, some people don't lose weight
KBC Group NV grew its position in shares of The ODP Co. ( NASDAQ:ODP – Free Report ) by 88.9% during the third quarter, HoldingsChannel reports. The firm owned 1,844 shares of the specialty retailer’s stock after buying an additional 868 shares during the period. KBC Group NV’s holdings in ODP were worth $55,000 as of its most recent SEC filing. Other institutional investors have also made changes to their positions in the company. Vanguard Group Inc. grew its holdings in ODP by 0.4% during the 1st quarter. Vanguard Group Inc. now owns 3,982,531 shares of the specialty retailer’s stock valued at $211,273,000 after purchasing an additional 16,584 shares in the last quarter. Clearline Capital LP grew its stake in shares of ODP by 108.7% during the second quarter. Clearline Capital LP now owns 124,886 shares of the specialty retailer’s stock valued at $4,904,000 after acquiring an additional 65,033 shares in the last quarter. Thompson Siegel & Walmsley LLC grew its stake in shares of ODP by 106.3% during the second quarter. Thompson Siegel & Walmsley LLC now owns 330,177 shares of the specialty retailer’s stock valued at $12,966,000 after acquiring an additional 170,149 shares in the last quarter. Creative Planning purchased a new stake in shares of ODP during the third quarter worth about $690,000. Finally, Wedge Capital Management L L P NC lifted its stake in shares of ODP by 66.3% in the third quarter. Wedge Capital Management L L P NC now owns 46,068 shares of the specialty retailer’s stock worth $1,371,000 after acquiring an additional 18,363 shares in the last quarter. 99.56% of the stock is owned by institutional investors and hedge funds. Analysts Set New Price Targets A number of equities research analysts have weighed in on ODP shares. UBS Group lowered their price objective on ODP from $30.00 to $28.00 and set a “neutral” rating for the company in a research note on Thursday, November 7th. StockNews.com raised shares of ODP from a “hold” rating to a “buy” rating in a research report on Thursday, November 7th. ODP Price Performance ODP opened at $27.26 on Friday. The company has a market capitalization of $821.07 million, a P/E ratio of -29.96, a PEG ratio of 0.58 and a beta of 1.48. The company has a 50-day moving average of $29.25 and a 200-day moving average of $33.90. The company has a debt-to-equity ratio of 0.28, a quick ratio of 0.47 and a current ratio of 0.92. The ODP Co. has a 1-year low of $23.69 and a 1-year high of $58.98. ODP ( NASDAQ:ODP – Get Free Report ) last announced its quarterly earnings data on Wednesday, November 6th. The specialty retailer reported $0.71 earnings per share for the quarter, missing the consensus estimate of $1.60 by ($0.89). The firm had revenue of $1.78 billion during the quarter, compared to the consensus estimate of $1.82 billion. ODP had a negative net margin of 0.52% and a positive return on equity of 12.15%. The firm’s quarterly revenue was down 11.3% compared to the same quarter last year. During the same period in the prior year, the firm earned $1.88 earnings per share. Equities analysts expect that The ODP Co. will post 3.26 EPS for the current fiscal year. About ODP ( Free Report ) The ODP Corporation provides business services and supplies, products, and digital workplace technology solutions for small, medium, and enterprise businesses in the United States, Puerto Rico, and the U.S. Virgin Islands. The company operates through four divisions: ODP Business Solutions, Office Depot, Veyer, and Varis. Further Reading Want to see what other hedge funds are holding ODP? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The ODP Co. ( NASDAQ:ODP – Free Report ). Receive News & Ratings for ODP Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ODP and related companies with MarketBeat.com's FREE daily email newsletter .
The people that president-elect Donald Trump has selected to lead federal health agencies in his second administration include a retired congressman, a surgeon and a former talk-show host. All of them could play pivotal roles in fulfilling a new political agenda that could change how the government goes about safeguarding Americans' health — from health care and medicines to food safety and science research. And if Congress approves, at the helm of the team as Department of Health and Human Services secretary will be prominent environmental lawyer and anti-vaccine organizer Robert F. Kennedy Jr. By and large, the nominees don't have experience running large bureaucratic agencies, but they know how to talk about health on TV . Centers for Medicare and Medicaid pick Dr. Mehmet Oz hosted a talk show for 13 years and is a well-known wellness and lifestyle influencer. The pick for the Food and Drug Administration, Dr. Marty Makary, and for surgeon general, Dr. Janette Nesheiwat, are frequent Fox News contributors. Many on the list were critical of COVID-19 measures like masking and booster vaccinations for young people. Some of them have ties to Florida like many of Trump's other Cabinet nominees: CDC pick Dr. Dave Weldon represented the state in Congress for 14 years and is affiliated with a medical group on the state's Atlantic coast. Nesheiwat's brother-in-law is Rep. Mike Waltz , R-Fla., tapped by Trump as national security adviser. Here's a look at the nominees' potential role in carrying out what Kennedy says is the task to “reorganize” agencies, which have an overall $1.7 billion budget; employ 80,000 scientists, researchers, doctors and other officials; and affect the lives of all Americans. The Atlanta-based CDC, with a $9.2 billion core budget, is charged with protecting Americans from disease outbreaks and other public health threats. Kennedy has long attacked vaccines and criticized the CDC, repeatedly alleging corruption at the agency. He said on a 2023 podcast that there is "no vaccine that is safe and effective,” and urged people to resist the CDC's guidelines on if and when kids should get vaccinated . Decades ago, Kennedy found common ground with Weldon , the 71-year-old nominee to run the CDC who served in the Army and worked as an internal medicine doctor before he represented a central Florida congressional district from 1995 to 2009. Starting in the early 2000s, Weldon had a prominent part in a debate about whether there was a relationship between a vaccine preservative called thimerosal and autism. He was a founding member of the Congressional Autism Caucus and tried to ban thimerosal from all vaccines. Kennedy, then a senior attorney for the Natural Resources Defense Council, believed there was a tie between thimerosal and autism and also charged that the government hid documents showing the danger. Since 2001, all vaccines manufactured for the U.S. market and routinely recommended for children 6 years or younger have contained no thimerosal or only trace amounts, with the exception of inactivated influenza vaccine. Meanwhile, study after study after study found no evidence that thimerosal caused autism. Weldon's congressional voting record suggests he may go along with Republican efforts to downsize the CDC, including to eliminate the National Center for Injury Prevention and Control, which works on topics like drownings, drug overdoses and shooting deaths. Weldon also voted to ban federal funding for needle-exchange programs as an approach to reduce overdoses, and the National Rifle Association gave him an “A” rating for his pro-gun rights voting record. Kennedy is extremely critical of the FDA, which has 18,000 employees and is responsible for the safety and effectiveness of prescription drugs, vaccines and other medical products — as well as overseeing cosmetics, electronic cigarettes and most foods. Makary, Trump’s pick to run the FDA, is closely aligned with Kennedy on several topics . The professor at Johns Hopkins University who is a trained surgeon and cancer specialist has decried the overprescribing of drugs, the use of pesticides on foods and the undue influence of pharmaceutical and insurance companies over doctors and government regulators. Kennedy has suggested he'll clear our “entire” FDA departments and also recently threatened to fire FDA employees for “aggressive suppression” of a host of unsubstantiated products and therapies, including stem cells, raw milk , psychedelics and discredited COVID-era treatments like ivermectin and hydroxychloroquine. Makary's contrarian views during the COVID-19 pandemic including the need for masking and giving young kids COVID vaccine boosters. But anything Makary and Kennedy might want to do when it comes to unwinding FDA regulations or revoking long-standing vaccine and drug approvals would be challenging. The agency has lengthy requirements for removing medicines from the market, which are based on federal laws passed by Congress. The agency provides health care coverage for more than 160 million people through Medicaid, Medicare and the Affordable Care Act, and also sets Medicare payment rates for hospitals, doctors and other providers. With a $1.1 trillion budget and more than 6,000 employees, Oz has a massive agency to run if confirmed — and an agency that Kennedy hasn't talked about much when it comes to his plans. While Trump tried to scrap the Affordable Care Act in his first term, Kennedy has not taken aim at it yet. But he has been critical of Medicaid and Medicare for covering expensive weight-loss drugs — though they're not widely covered by either . Trump said during his campaign that he would protect Medicare, which provides insurance for older Americans. Oz has endorsed expanding Medicare Advantage — a privately run version of Medicare that is popular but also a source of widespread fraud — in an AARP questionnaire during his failed 2022 bid for a U.S. Senate seat in Pennsylvania and in a 2020 Forbes op-ed with a former Kaiser Permanente CEO. Oz also said in a Washington Examiner op-ed with three co-writers that aging healthier and living longer could help fix the U.S. budget deficit because people would work longer and add more to the gross domestic product. Neither Trump nor Kennedy have said much about Medicaid, the insurance program for low-income Americans. Trump's first administration reshaped the program by allowing states to introduce work requirements for recipients. Kennedy doesn't appear to have said much publicly about what he'd like to see from surgeon general position, which is the nation's top doctor and oversees 6,000 U.S. Public Health Service Corps members. The surgeon general has little administrative power, but can be an influential government spokesperson on what counts as a public health danger and what to do about it — suggesting things like warning labels for products and issuing advisories. The current surgeon general, Vivek Murthy, declared gun violence as a public health crisis in June. Trump's pick, Nesheiwat, is employed as a New York City medical director with CityMD, a group of urgent care facilities in the New York and New Jersey area, and has been at City MD for 12 years. She also has appeared on Fox News and other TV shows, authored a book on the “transformative power of prayer” in her medical career and endorses a brand of vitamin supplements. She encouraged COVID-19 vaccines during the pandemic, calling them “a gift from God” in a February 2021 Fox News op-ed, as well as anti-viral pills like Paxlovid. In a 2019 Q&A with the Women in Medicine Legacy Foundation , Nesheiwat said she is a “firm believer in preventive medicine” and “can give a dissertation on hand-washing alone.” As of Saturday, Trump had not yet named his choice to lead the National Institutes of Health, which funds medical research through grants to researchers across the nation and conducts its own research. It has a $48 billion budget. Kennedy has said he'd pause drug development and infectious disease research to shift the focus to chronic diseases. He'd like to keep NIH funding from researchers with conflicts of interest, and criticized the agency in 2017 for what he said was not doing enough research into the role of vaccines in autism — an idea that has long been debunked . Associated Press writers Amanda Seitz and Matt Perrone and AP editor Erica Hunzinger contributed to this report. The Associated Press Health and Science Department receives support from the Howard Hughes Medical Institute’s Science and Educational Media Group and the Robert Wood Johnson Foundation. The AP is solely responsible for all content.Denbighshire’s cabinet member for finance said the council should be proud of its achievements, despite multiple ‘red marks’ in a performance objective report. The corporate plan performance report details the council’s successes, areas for improvement, and failures against its corporate plan. At a cabinet meeting this week, members were presented with a quarterly report documenting Denbighshire’s objectives between April and September for strategic equality and its seven governance areas. The governance areas include corporate planning, financial planning, performance management, risk management, workforce planning, assets, and procurement. The council’s progress in the report was marked green, amber, and red, according to how successful it had been. Numerous areas were highlighted in red, including housing list waiting times, the number of homes for the disabled awaiting improvements, and several markers for homelessness. Other areas marked in red included those involving repair work to damaged roads, children in poverty, and net carbon zero targets. The report also acknowledged Denbighshire’s failings around the launch of its new recycling and bin collection scheme. But speaking at a cabinet meeting this week, cabinet member for finance Cllr Gwyneth Ellis preferred to focus on the areas the council had had success. Positives in the report included the council reducing its reliance on bed and breakfasts for those waiting for housing. Other areas of success included the council being the highest performing housing stock-holding council in Wales, according to the Welsh Government’s Social Landlords’ Tenant Satisfaction Survey. The report also highlighted ‘excellent community benefits’ from two large procurements as well as other areas of success. Cllr Ellis commented: “It is very easy to feel sad in the current (financial) climate with the council having to find massive savings and having to accept that services will inevitably suffer as a result. “So it is easy to look at this report and see the reds and the amber, but in my opinion, it is much more important to look at the green.” She added: “I think it is incredible that we as a council are still able to do so much well even when facing exceptional challenges, and that is an indication of the hard work and perseverance of our staff in my opinion. I think it is important to acknowledge that when we see a report like this.” Denbighshire increased council tax by 9.34% last year whilst cutting services, despite receiving the highest local government settlement in North Wales. Last time around, council leaders pointed to an increase in costs and pressures due to inflation. The authority’s medium-term financial plan forecasts cost pressures ranging from £12m to £26m in the red in 2025/26 with a mid-range of £18m. Consequently the council has modelled for a council tax rise ranging between a 6% and 12% increase. Cabinet unanimously confirmed the report for approval.
NoneNone
All three major US stock indexes scored record closing highs on Wednesday as technology shares rallied after upbeat results from Salesforce and as comments by Federal Reserve Chair Jerome Powell gave a late boost to the market. or signup to continue reading The economy is stronger than it appeared in September when the central bank began cutting interest rates, allowing policymakers to potentially be a little more cautious in reducing rates further, Powell said at a New York Times event. Powell's comments overall along with a Fed economic activity report added to the upbeat tone in the market, said Peter Cardillo, chief market economist at Spartan Capital Securities in New York. The Fed said in a summary of surveys and interviews from across the country known as the "Beige Book" that US economic activity has expanded slightly in most regions since early October. Powell "was very upbeat about economy, and he said we're making progress on inflation ... that's good news for stocks in general," Cardillo said. Investors expect a third consecutive interest-rate cut at the central bank's December 17-18 meeting. Salesforce jumped 11 per cent and hit an all-time high after the enterprise cloud company beat analyst estimates for third-quarter revenue and raised the lower end of its annual revenue forecast. Other cloud companies also advanced. The S&P 500 technology index hit a record closing high, along with the communication services and consumer discretionary indexes. Also in the tech space, Marvell Technology rallied 23.2 per cent and also hit a record high after the chipmaker forecast fourth-quarter revenue above analyst estimates. An index of semiconductors rose 1.7 per cent, while Nvidia was up 3.5 per cent. The Dow Jones Industrial Average rose 308.91 points, or 0.69 per cent, to 45,014.44, the S&P 500 gained 36.59 points, or 0.60 per cent, to 6,086.47 and the Nasdaq Composite gained 254.21 points, or 1.30 per cent, to 19,735.12. Investors eagerly await monthly US jobs data due on Friday and jobless claims data on Thursday. Earlier Wednesday, US private payrolls data showed a modest increase in November. Separately, a survey from the Institute for Supply Management showed US services sector activity slowed in November after big gains in recent months. The final reading of the S&P services survey was revised lower to 56.1. "Recent economic data has pretty much confirmed the Fed will cut rates in December," said Sam Stovall, chief investment strategist at CFRA Research in New York. Friday's jobs report is "like the granddaddy of employment reports this week," he said. Advancing issues outnumbered decliners by a 1.2-to-1 ratio on the NYSE. There were 367 new highs and 79 new lows on the NYSE. On the Nasdaq, 2,372 stocks rose and 1,930 fell as advancing issues outnumbered decliners by a 1.23-to-1 ratio. Volume on US exchanges was 13.06 billion shares, compared with the 14.89 billion average for the full session over the last 20 trading days. Advertisement Sign up for our newsletter to stay up to date. We care about the protection of your data. Read our . AdvertisementSam Darnold leads game-winning drive in OT and Vikings beat Bears 30-27 after blowing late lead